Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
United Therapeutics disclosed it will present new clinical data at the CHEST 2026 meeting in Phoenix on Oct. 18-21, 2026. An oral update will report how inhaled treprostinil performed in the TETON-IPF program in slowing disease worsening in idiopathic pulmonary fibrosis. Separate PHINDER analyses will be presented on m
For best results when printing this announcement, please click on link below: United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting A pre-specified subgroup analysis from the phase 3 ADVANCE OUTCOMES study showed that ralinepag reduced the risk of clinical worsening in patients with pulmonary arterial